Bruxism, Sleep — OstiSense Biosensor in Bruxism Reduction - A Clinical Study
Citation(s)
Bowley JF, Stockstill JW, Pierce CJ Reliability and validity of instrumentation used to record nocturnal clenching and/or grinding. J Orofac Pain. 1993 Fall;7(4):378-85.
Carra MC, Huynh N, Lavigne G Sleep bruxism: a comprehensive overview for the dental clinician interested in sleep medicine. Dent Clin North Am. 2012 Apr;56(2):387-413. doi: 10.1016/j.cden.2012.01.003. Review.
Cassisi JE, McGlynn FD, Belles DR EMG-activated feedback alarms for the treatment of nocturnal bruxism: current status and future directions. Biofeedback Self Regul. 1987 Mar;12(1):13-30. Review.
Foster PS Use of the Calmset 3 biofeedback/relaxation system in the assessment and treatment of chronic nocturnal bruxism. Appl Psychophysiol Biofeedback. 2004 Jun;29(2):141-7.
Gavish A, Halachmi M, Winocur E, Gazit E Oral habits and their association with signs and symptoms of temporomandibular disorders in adolescent girls. J Oral Rehabil. 2000 Jan;27(1):22-32.
Gu W, Yang J, Zhang F, Yin X, Wei X, Wang C Efficacy of biofeedback therapy via a mini wireless device on sleep bruxism contrasted with occlusal splint: a pilot study. J Biomed Res. 2015 Apr;29(2):160-8. doi: 10.7555/JBR.28.20130145. Epub 2014 Nov 18.
Jagger R The effectiveness of occlusal splints for sleep bruxism. Evid Based Dent. 2008;9(1):23. doi: 10.1038/sj.ebd.6400569.
Klasser GD, Greene CS, Lavigne GJ Oral appliances and the management of sleep bruxism in adults: a century of clinical applications and search for mechanisms. Int J Prosthodont. 2010 Sep-Oct;23(5):453-62. Review.
Koyano K, Tsukiyama Y, Ichiki R, Kuwata T Assessment of bruxism in the clinic. J Oral Rehabil. 2008 Jul;35(7):495-508. doi: 10.1111/j.1365-2842.2008.01880.x. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
